Hospital Clinic Barcelona and Bellvitge University Hospital have started using the RAID-CRC test from biotechnology firm GoodGut for early detection of colorectal cancer.

RAID-CRC is a fast, affordable, easy-to-use, non-invasive test and the first to use specific bacterial biomarkers in stool samples. This new, clinically proven method can reduce the number of false positives by 61%, which means those unnecessary colonoscopies don't have to be done.

“With the current healthcare restrictions due to COVID-19, our priority is to identify the patients who would most benefit from a colonoscopy,” explained Dr Francesc Balaguer, head of Gastroenterology at Hospital Clinic, and Dr Jordi Guardiola, who holds the same position at Bellvitge Hospital.

More information

You may also be interested:

• GoodGut raises €500,000 for a test that will improve colorectal-cancer screening
• GoodGut and Palex to launch first non-invasive diagnostic tests for IBS and IBD